Tech Company Financing Transactions

Edge Therapeutics Funding Round

Private investors joined a $7.9 million funding round for Edge Therapeutics. The financing round was announced by the company on 11/14/2014.

Transaction Overview

Company Name
Announced On
11/14/2014
Transaction Type
Venture Equity
Amount
$7,937,236
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
300 Connell Dr. 4000
Berkeley Heights, NJ 07922
USA
Phone
Undisclosed
Email Address
Overview
Edge Therapeutics, a pharmaceutical company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Profile
Edge Therapeutics LinkedIn Company Profile
Social Media
Edge Therapeutics Company Twitter Account
Company News
Edge Therapeutics News
Facebook
Edge Therapeutics on Facebook
YouTube
Edge Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Bedu-Addo
  Frank Bedu-Addo LinkedIn Profile  Frank Bedu-Addo Twitter Account  Frank Bedu-Addo News  Frank Bedu-Addo on Facebook
Chief Financial Officer
Andrew Saik
  Andrew Saik LinkedIn Profile  Andrew Saik Twitter Account  Andrew Saik News  Andrew Saik on Facebook
Chief Medical Officer
Lauren Wood
  Lauren Wood LinkedIn Profile  Lauren Wood Twitter Account  Lauren Wood News  Lauren Wood on Facebook
Chief Scientific Officer
Gregory Conn
  Gregory Conn LinkedIn Profile  Gregory Conn Twitter Account  Gregory Conn News  Gregory Conn on Facebook
VP - Administration
Bert Marchio
  Bert Marchio LinkedIn Profile  Bert Marchio Twitter Account  Bert Marchio News  Bert Marchio on Facebook
VP - General Counsel
Brad Middlekauff
  Brad Middlekauff LinkedIn Profile  Brad Middlekauff Twitter Account  Brad Middlekauff News  Brad Middlekauff on Facebook
VP - Operations
Alpaslan Yaman
  Alpaslan Yaman LinkedIn Profile  Alpaslan Yaman Twitter Account  Alpaslan Yaman News  Alpaslan Yaman on Facebook
VP - Regulatory Affairs
Alyssa Wyant
  Alyssa Wyant LinkedIn Profile  Alyssa Wyant Twitter Account  Alyssa Wyant News  Alyssa Wyant on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/14/2014: Monteris Medical venture capital transaction
Next: 11/14/2014: Quandl venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary